MYC and colorectal cancer: The finding that MYC slightly affected CLK inhibitor‐dependent AS events was also supported by a previous finding that CLK inhibitor, T3‐dependent AS events mostly (~ 75%) overlapped between the hTERT un‐transformed fibroblast cells and MYC‐amplified HCT116 colorectal cancer cells (Funnell et al, 2017).